Your browser doesn't support javascript.
loading
Target trial emulation using cohort studies: estimating the effect of antihypertensive medication initiation on incident dementia.
Bennett, Erin E; Liu, Chelsea; Stapp, Emma K; Gianattasio, Kan Z; Zimmerman, Scott C; Wei, Jingkai; Griswold, Michael E; Fitzpatrick, Annette L; Gottesman, Rebecca F; Launer, Lenore J; Windham, B Gwen; Levine, Deborah A; Fohner, Alison E; Glymour, M Maria; Power, Melinda C.
Afiliación
  • Bennett EE; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Liu C; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Stapp EK; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Gianattasio KZ; Department of Health Care Evaluation, NORC at the University of Chicago, Bethesda, MD, USA.
  • Zimmerman SC; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.
  • Wei J; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
  • Griswold ME; Memory Impairment and Neurodegenerative Dementia Center, University of Mississippi Medical Center, Jackson, MS, USA.
  • Fitzpatrick AL; Department of Family Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
  • Gottesman RF; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
  • Launer LJ; National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
  • Windham BG; Laboratory of Epidemiology and Population Sciences, National Institute of Aging, Bethesda, MD, USA.
  • Levine DA; Memory Impairment and Neurodegenerative Dementia Center, University of Mississippi Medical Center, Jackson, MS, USA.
  • Fohner AE; Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Glymour MM; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
  • Power MC; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.
Epidemiology ; 2024 Oct 01.
Article en En | MEDLINE | ID: mdl-39352756
ABSTRACT

BACKGROUND:

Observational studies link high midlife systolic blood pressure to increased dementia risk. However, synthesis of evidence from randomized controlled trials has not definitively demonstrated that antihypertensive medication use reduces dementia risk. Here, we emulate target trials of antihypertensive medication initiation on incident dementia using three cohort studies, with attention to potential violations of necessary assumptions.

METHODS:

We emulated trials of antihypertensive medication initiation on incident dementia using data from the Atherosclerosis Risk in Communities (ARIC) study, Cardiovascular Health Study (CHS), and Health and Retirement Study (HRS). We used data-driven methods to restrict participants to initiators and non-initiators with overlap in propensity scores and positive control outcomes to look for violations of positivity and exchangeability assumptions.

RESULTS:

Analyses were limited by the small number of cohort participants who met eligibility criteria. Associations between antihypertensive medication initiation and incident dementia were inconsistent and imprecise (ARIC HR = 0.30 [0.05, 1.93]; CHS HR = 0.66 [0.27, 1.64]; HRS HR = 1.09 [0.75, 1.59]). More stringent propensity score restriction had little effect on findings. Sensitivity analyses using a positive control outcome unexpectedly suggested antihypertensive medication initiation increased risk of coronary heart disease in all three samples.

CONCLUSIONS:

Positive control outcome analyses suggested substantial residual confounding in effect estimates from our target trials, precluding conclusions about the impact of antihypertensive medication initiation on dementia risk through target trial emulation. Formalized processes for identifying violations of necessary assumptions will strengthen confidence in target trial emulation and avoid inappropriate confidence in emulated trial results.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Epidemiology Asunto de la revista: EPIDEMIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Epidemiology Asunto de la revista: EPIDEMIOLOGIA Año: 2024 Tipo del documento: Article